mfn-cus-news

Nanologica’s Annual Report 2022 Published

Nanologica AB’s annual report for 2022 is now published on the company’s website. The annual report in Swedish, and an English translation, is available on www.nanologica.com as a pdf. The annual report in Swedish is also available in the European Single Electronic Format (ESEF). Swedish: https://nanologica.com/category/finansiella-rapporter/ English translation: https://nanologica.com/category/financial-reports/   For further information, please contact: Johanna Johansson, Director IR, Communications and Marketing Ph: +46 72 211 21 90 or e-mail: ir@nanologica.com This information is information that

Read more »

Nanologica’s Interim Report Jan-Sep 2022

Report presentation Q3 2022   FINANCIAL SUMMARY Net sales for the third quarter amounted to TSEK 401 (2,119) and for the nine-month period to TSEK 881 (12,238) The operating result for the quarter amounted to TSEK -9,610 (-11,718) and for the nine-month period to TSEK -37,599 (-26,581) Result after tax for the quarter amounted to TSEK -10,988 (-12,546) and for the nine-month period to TSEK -40,376 (-29,607) Earnings per share before and after dilution were

Read more »

Change of Number of Shares in Nanologica AB (publ)

The number of shares and votes in Nanologica AB (publ) has changed during the month of October as a result of the completion of the previously communicated preferential rights issue. As previously communicated, Nanologica's board of directors on August 23, 2022, decided on a new share issue of approximately MSEK 94 with preferential rights for existing shareholders, in order to finance intensified investments in preparative chromatography. On October 10, Nanologica announced that the rights issue

Read more »

Nanologica Announces Nomination Committee for the Annual General Meeting 2023

In accordance with the resolution at the Annual General Meeting (“AGM”) on June 2, 2022, the chairman of the board has contacted the company's three largest owners or ownership groups in terms of votes as of September 30, 2022, each of whom has appointed a representative to constitute the nomination committee of Nanologica AB for the 2023 AGM. The nomination committee for Nanologica AB's 2023 AGM thus consists of the following three members: Carl-Johan Spak

Read more »

Nanologica Raises MSEK 79,8 in Rights Issue

 NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE ADDITIONAL REGISTRATION OR OTHER MEASURES.  Nanologica AB (publ) (”Nanologica" or the "Company") today announces the outcome of the new shares issue with preferential rights for Nanologica's existing shareholders (the

Read more »

Nanologica Receives Order for Silica for Preparative Chromatography from US Customer

Nanologica AB (publ) has received an order for the company's silica for preparative chromatography to a value of approximately TSEK 230. The order comes from a customer in the North American market. During 2022, Nanologica has completed the up-scaling to large-scale production of the company’s commercial silica for preparative chromatography, NLAB Saga®.  This order is a direct consequence of the company now being able to deliver the volumes of silica required for customers to be

Read more »